Eduardo T. Calderon

Eduardo T. Calderon

Neurology | Sleep Medicine
3949 Sunforest Court
Suite 105
Toledo, OH 43623

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Excellent Response to Combined 223 Ra-dichloride and Enzalutamide After Failure of 177 Lu-PSMA Radioligand Therapy.

Excellent Response to Combined 223 Ra-dichloride and Enzalutamide After Failure of 177 Lu-PSMA Radioligand Therapy.

Journal: Clinical nuclear medicine
Published: January 24, 2026

Age- and BMI-Dependent Psoas and Gluteus Muscle Mass in 27,805 Participants of the Population-Based German National Cohort (NAKO Gesundheitsstudie): A Deep-Learning 3T MRI Study.

Age- and BMI-Dependent Psoas and Gluteus Muscle Mass in 27,805 Participants of the Population-Based German National Cohort (NAKO Gesundheitsstudie): A Deep-Learning 3T MRI Study.

Journal: Diagnostics (Basel, Switzerland)
Published: December 07, 2025

Exploring extended [18F]FDG kinetics in lymphoma with ultra-late LAFOV-PET/CT.

Exploring extended [18F]FDG kinetics in lymphoma with ultra-late LAFOV-PET/CT.

Journal: European journal of nuclear medicine and molecular imaging
Published: October 04, 2025

PET-imaging derived prognostic factors for prostate cancer patients with visceral metastases receiving [177Lu]Lu-PSMA radiopharmaceutical therapy (RPT).

PET-imaging derived prognostic factors for prostate cancer patients with visceral metastases receiving [177Lu]Lu-PSMA radiopharmaceutical therapy (RPT).

Journal: European journal of nuclear medicine and molecular imaging
Published: September 26, 2025

Continuous bed motion versus step-and-shoot acquisition in LAFOV PET/CT: insights from multi-phantom and patient studies.

Continuous bed motion versus step-and-shoot acquisition in LAFOV PET/CT: insights from multi-phantom and patient studies.

Journal: EJNMMI physics
Published: September 19, 2025

One-day dual-tracer examination in neuroendocrine neoplasms: a real advantage of low activity LAFOV PET imaging.

One-day dual-tracer examination in neuroendocrine neoplasms: a real advantage of low activity LAFOV PET imaging.

Journal: European journal of nuclear medicine and molecular imaging
Published: September 13, 2024

Focal Unspecific Bone Uptake on [18F]PSMA-1007 PET: Evaluation Analog PROMISE Criteria and Validation via PET/CT Follow-Up.

Focal Unspecific Bone Uptake on [18F]PSMA-1007 PET: Evaluation Analog PROMISE Criteria and Validation via PET/CT Follow-Up.

Journal: Diagnostics (Basel, Switzerland)
Published: August 16, 2024

Optimizing stroke lesion segmentation: A dual-approach using Gaussian mixture models and nnU-Net.

Optimizing stroke lesion segmentation: A dual-approach using Gaussian mixture models and nnU-Net.

Journal: Computers in biology and medicine
Published: August 02, 2024

Low-activity [18F]-somatostatin receptor (SSTR) imaging using [18F]SiTATE on a long axial field-of-view PET/CT scanner.

Low-activity [18F]-somatostatin receptor (SSTR) imaging using [18F]SiTATE on a long axial field-of-view PET/CT scanner.

Journal: EJNMMI physics
Published: May 20, 2024

A novel approach to guide GD2-targeted therapy in pediatric tumors by PET and [64Cu]Cu-NOTA-ch14.18/CHO.

A novel approach to guide GD2-targeted therapy in pediatric tumors by PET and [64Cu]Cu-NOTA-ch14.18/CHO.

Journal: Theranostics
Published: November 22, 2023

Image Quality and Quantitative PET Parameters of Low-Dose [18F]FDG PET in a Long Axial Field-of-View PET/CT Scanner.

Image Quality and Quantitative PET Parameters of Low-Dose [18F]FDG PET in a Long Axial Field-of-View PET/CT Scanner.

Journal: Diagnostics (Basel, Switzerland)
Published: September 29, 2023

Repurposing the mucolytic agent ambroxol for treatment of sub-acute and chronic ischaemic stroke.

Repurposing the mucolytic agent ambroxol for treatment of sub-acute and chronic ischaemic stroke.

Journal: Brain communications
Published: June 20, 2022
Showing 1-12 of 12

Last Updated: 09/26/2026